中草药

葛根素多靶向抗氧化机制及其疾病干预策略

PDF下载

李含雪, 任秋月, 张嘉敏, 张锦宇, 姬熙君, 冯志海

中草药 | 综述 2026,57(5): 1924-1937

收起

中草药 |综述 2026 , 57 (5) : 1924 -1937

葛根素多靶向抗氧化机制及其疾病干预策略

全屏

李含雪, 任秋月, 张嘉敏, 张锦宇, 姬熙君, 冯志海

作者信息

通讯作者:

冯志海

作者简介:

李含雪: 李含雪,硕士研究生,研究方向为中医药防治内分泌疾病。E-mail:2077985694@qq.com

Multitargeted antioxidant mechanisms of puerarin and its disease intervention strategies

LI Hanxue, REN Qiuyue, ZHANG Jiamin, ZHANG Jinyu, JI Xijun, FENG Zhihai

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.05.028

文章导航

摘要

收起

氧化应激是推动多种慢性疾病发生与演进的核心病理环节，其特征是活性氧过度积累与内源性抗氧化防御失衡。葛根素作为从葛根Puerariae Lobatae Radix中提取的天然异黄酮苷类化合物，具有多靶向抗氧化活性。研究表明，葛根素可通过直接清除自由基、激活内源性抗氧化系统、抑制促氧化酶、调控核因子E2相关因子2、丝裂原活化蛋白激酶、蛋白激酶B等关键信号通路及改善线粒体、内质网和溶酶体等细胞器功能等机制，显著缓解氧化应激及铁死亡、焦亡与凋亡等细胞死亡过程。围绕葛根素的多靶向抗氧化机制、临床应用现状、药动学挑战及新型递药系统的研究进展进行系统总结，为推动葛根素成为治疗氧化应激相关疾病的精准靶向药物提供理论依据。

关键词

葛根素 / 抗氧化应激 / 临床应用 / 药动学 / 药物递送系统

Abstract

收起

Oxidative stress is a central pathological process driving the onset and progression of multiple chronic diseases, characterized by excessive accumulation of reactive oxygen species and imbalance of endogenous antioxidant defenses. Puerarin, a natural isoflavone glycoside extracted from Gegen (Puerariae Lobatae Radix), exhibits potent multi-target antioxidant activities. Accumulating evidence indicates that puerarin alleviates oxidative stress and cell death processes such as ferroptosis, pyroptosis and apoptosis by directly scavenging free radicals, activating endogenous antioxidant systems, inhibiting pro-oxidant enzymes, modulating key signaling pathways such as nuclear factor erythroid 2-related factor 2 (Nrf2), mitogen-activated protein kinase (MAPK), and protein kinase B (Akt), and improving the functional homeostasis of cellular organelles including mitochondria, endoplasmic reticulum, and lysosomes. This review systematically summarizes the multi-target antioxidant mechanisms of puerarin, its current clinical applications, pharmacokinetic limitations, and recent advances in novel drug delivery systems, aiming to provide a theoretical basis for the development of puerarin as a precision-targeted therapeutic agent for oxidative stress-related diseases.

Key words

puerarin / antioxidant stress / clinical application / pharmacokinetics / drug delivery systems

引用本文

李含雪, 任秋月, 张嘉敏, 张锦宇, 姬熙君, 冯志海. 葛根素多靶向抗氧化机制及其疾病干预策略. 中草药, 2026 , 57 (5) : 1924 -1937 . DOI: 10.7501/j.issn.0253-2670.2026.05.028

LI Hanxue, REN Qiuyue, ZHANG Jiamin, ZHANG Jinyu, JI Xijun, FENG Zhihai. Multitargeted antioxidant mechanisms of puerarin and its disease intervention strategies[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (5) : 1924 -1937 . DOI: 10.7501/j.issn.0253-2670.2026.05.028

基金

收起

国家自然科学青年基金资助项目 (82305019); 河南省科技攻关项目 (242102311252)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: The clash between damage and metabolic needs[J]. Cell Death Differ, 2015, 22(3): 377-388.
Georgiou C D, Margaritis L H. Oxidative stress and NADPH oxidase: Connecting electromagnetic fields, cation channels and biological effects[J]. Int J Mol Sci, 2021, 22(18): 10041.
Juan C A, Pérez de la Lastra J M, Plou F J, et al. The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies[J]. Int J Mol Sci, 2021, 22(9): 4642.
Ulasov A V, Rosenkranz A A, Georgiev G P, et al. Nrf2/Keap1/ARE signaling: Towards specific regulation[J]. Life Sci, 2022, 291: 120111.
Liga S, Paul C. Puerarin: A promising flavonoid: Biosynthesis, extraction methods, analytical techniques, and biological effects[J]. Int J Mol Sci, 2024, 25(10): 5222.
陈焱, 封俨宸, 廖紫云, 等. 葛根素调节肥胖机制的研究进展[J]. 中草药, 2025, 56(11): 4103-4114.
Zhou H K, Li X Z, Shang Y X, et al. Radical scavenging activity of puerarin: A theoretical study[J]. Antioxidants, 2019, 8(12): 590.
于文利, 王文锋, 赵亚平, 等. 脉冲辐解研究葛根素对自由基的清除活性[J]. 中国科学B辑, 2003, 33(2): 172-175.
Wang Y, Branicky R, Noë A, et al. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling[J]. J Cell Biol, 2018, 217(6): 1915-1928.
Ma L L, Sun L, Wang Y X, et al. Association between HO-1 gene promoter polymorphisms and diseases (Review)[J]. Mol Med Rep, 2022, 25(1): 29.
He L, He T, Farrar S, et al. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species[J]. Cell Physiol Biochem, 2017, 44(2): 532-553.
Li C C, Pan Z, Xu T J, et al. Puerarin induces the upregulation of glutathione levels and nuclear translocation of Nrf2 through PI3K/Akt/GSK-3β signaling events in PC12 cells exposed to lead[J]. Neurotoxicol Teratol, 2014, 46: 1-9.
Huang Y, Wu H G, Hu Y M, et al. Puerarin attenuates oxidative stress and ferroptosis via AMPK/PGC1α/Nrf2 pathway after subarachnoid hemorrhage in rats[J]. Antioxidants, 2022, 11(7): 1259.
Zhou J X, Zhang N H, Aldhahrani A, et al. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation[J]. Front Immunol, 2022, 13: 956688.
Lin S J, Cheng Y, Chen X X, et al. Puerarin delays the progression of muscle atrophy in mice with dexamethasone-induced sarcopenia through inhibiting the TNF-α/NF-κB pathway[J]. Food Sci Nutr, 2025, 13(4): e70166.
Li W C, Xu X T, Dong D D, et al. Up-regulation of thioredoxin system by puerarin inhibits lipid uptake in macrophages[J]. Free Radic Biol Med, 2021, 162: 542-554.
Zheng G M, Yu C, Yang Z. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation[J]. Int J Oncol, 2012, 40(5): 1610-1618.
Hao L N, Wang M, Ma J L, et al. Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression[J]. Acta Physiologica Sinica, 2012, 64(2): 199-206.
Bao M H, Zhang Y W, Lou X Y, et al. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS[J]. Can J Physiol Pharmacol, 2014, 92(4): 299-306.
Gao H L, Yang Y, Tian H, et al. Puerarin alleviates blood pressure via inhibition of ROS/TLR4/NLRP3 inflammasome signaling pathway in the hypothalamic paraventricular nucleus of salt-induced prehypertensive rats[J]. Nutrients, 2024, 16(16): 2580.
Zhang P, Zhang Y X, Wang L, et al. Reversal of NADPH oxidase-dependent early oxidative and inflammatory responses in chronic obstructive pulmonary disease by puerarin[J]. Oxid Med Cell Longev, 2022, 2022: 5595781.
Tonelli C, Chio I I C, Tuveson D A. Transcriptional regulation by Nrf2[J]. Antioxid Redox Signal, 2018, 29(17): 1727-1745.
尹怡林. 柚皮素通过调控Keap1/Nrf2/ARE通路减轻LPS诱导禽肺炎氧化损伤的作用机制研究[D]. 哈尔滨: 东北农业大学, 2025.
Zhou W H, He H, Wei Q, et al. Puerarin protects against acetaminophen-induced oxidative damage in liver through activation of the Keap1/Nrf2 signaling pathway[J]. Food Sci Nutr, 2023, 11(10): 6604-6615.
Mo Q T, Li S P, You S Q, et al. Puerarin reduces oxidative damage and photoaging caused by UVA radiation in human fibroblasts by regulating Nrf2 and MAPK signaling pathways[J]. Nutrients, 2022, 14(22): 4724.
Jeon Y D, Lee J H, Lee Y M, et al. Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model[J]. Biomed Pharmacother, 2020, 124: 109847.
Li X M, Zhang J, Zhang X J, et al. Puerarin suppresses MPP(+)/MPTP-induced oxidative stress through an Nrf2-dependent mechanism[J]. Food Chem Toxicol, 2020, 144: 111644.
王佳音, 郑思, 李明, 等. 葛根素通过Nrf2/SLC7A11/ GPX4通路抑制过氧化氢诱导的RSC96细胞铁死亡[J]. 神经解剖学杂志, 2025, 41(2): 194-200.
Song Q T, Jian W Y, Zhang Y Y, et al. Puerarin attenuates iron overload-induced ferroptosis in retina through a Nrf2-mediated mechanism[J]. Mol Nutr Food Res, 2024, 68(4): e2300123.
Chen X M, Huang C A, Sun H Q, et al. Puerarin suppresses inflammation and ECM degradation through Nrf2/HO-1 axis in chondrocytes and alleviates pain symptom in osteoarthritic mice[J]. Food Funct, 2021, 12(5): 2075-2089.
刘衍冬, 乔巍, 裴兆辉, 等. 葛根素通过Nrf2/ARE/ HO-1信号通路抑制铁死亡改善心肌肥厚的心肌收缩功能机制[J]. 中国中药杂志, 2025, 50(16): 4679-4689.
Zhang W H, Xu M C, Wen S Q, et al. Puerarin alleviates cadmium-induced rat neurocyte injury by alleviating Nrf2-mediated oxidative stress and inhibiting mitochondrial unfolded protein response[J]. Ecotoxicol Environ Saf, 2022, 247: 114239.
Hu Y W, Li H T, Li R L, et al. Puerarin protects vascular smooth muscle cells from oxidized low-density lipoprotein-induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways[J]. Exp Ther Med, 2020, 20(6): 270.
Lv B C, Huo F Q, Dang X J, et al. Puerarin attenuates N-methyl-D-aspartic acid-induced apoptosis and retinal ganglion cell damage through the JNK/p38 MAPK pathway[J]. J Glaucoma, 2016, 25(9): e792-e801.
Li H T, Zhong K, Xia Y F, et al. Puerarin improves busulfan-induced disruption of spermatogenesis by inhibiting MAPK pathways[J]. Biomed Pharmacother, 2023, 165: 115231.
Ma J Q, Ding J, Xiao Z H, et al. Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway[J]. Food Chem Toxicol, 2014, 71: 264-271.
Zhang Q Q, Yao M, Qi J J, et al. Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway[J]. Front Pharmacol, 2023, 14: 1134380.
Yen P T, Huang S G, Hsu J H, et al. Anti-inflammatory and anti-oxidative effects of puerarin in postmenopausal cardioprotection: Roles of Akt and heme oxygenase-1[J]. Am J Chin Med, 2023, 51(1): 149-168.
Gou H Q, Chen X, Zhu X M, et al. Sequestered SQSTM1/p62 crosstalk with Keap1/Nrf2 axis in hPDLCs promotes oxidative stress injury induced by periodontitis[J]. Free Radic Biol Med, 2022, 190: 62-74.
Huang D H, Peng Y Z, Ma K G, et al. Puerarin relieved compression-induced apoptosis and mitochondrial dysfunction in human nucleus pulposus mesenchymal stem cells via the PI3K/Akt pathway[J]. Stem Cells Int, 2020, 2020: 7126914.
Bhatti J S, Bhatti G K, Reddy P H. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(5): 1066-1077.
Yang C W, Liu H M, Chang Z Y, et al. Puerarin modulates hepatic farnesoid X receptor and gut microbiota in high-fat diet-induced obese mice[J]. Int J Mol Sci, 2024, 25(10): 5274.
Sheng G G, Wu Y, Liu H Y, et al. Puerarin improves cancer-induced bone pain by recovering mitochondrial dysfunction in the spinal cord[J]. J Neuroimmune Pharmacol, 2025, 20(1): 67.
Hu F J, Hu T, He A D, et al. Puerarin protects myocardium from ischaemia/reperfusion injury by inhibiting ferroptosis through downregulation of VDAC1[J]. J Cell Mol Med, 2024, 28(24): e70313.
Wan X M, Zheng C, Zhou X L. Puerarin prevents cadmium-induced mitochondrial fission in AML-12 cells via SIRT1-dependent pathway[J]. Ecotoxicol Environ Saf, 2022, 248: 114302.
Chen X F, Yi L, Song S Y, et al. Puerarin attenuates palmitate-induced mitochondrial dysfunction, impaired mitophagy and inflammation in L6 myotubes[J]. Life Sci, 2018, 206: 84-92.
Xiang Y L, Li Z L, He X, et al. Puerarin relives inflammation, bone destruction and facilitates osteogenic differentiation in periodontitis by enhancing mitochondrial autophagy via activating mitochondrial mitofusin 2[J]. Stem Cell Res Ther, 2025, 16(1): 218.
Wen S Q, Wang L, Wang T, et al. Puerarin alleviates cadmium-induced mitochondrial mass decrease by inhibiting PINK1-Parkin and Nix-mediated mitophagy in rat cortical neurons[J]. Ecotoxicol Environ Saf, 2022, 230: 113127.
Wang L, Jiang W Z, Wang J, et al. Puerarin inhibits FUNDC1-mediated mitochondrial autophagy and CSE-induced apoptosis of human bronchial epithelial cells by activating the PI3K/Akt/mTOR signaling pathway[J]. Aging, 2022, 14(3): 1253-1264.
Chen X Y, Shi C R, He M H, et al. Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8(1): 352.
Xue J J, Ren H L, Zhang Q, et al. Puerarin attenuates myocardial ischemic injury and endoplasmic reticulum stress by upregulating the Mzb1 signal pathway[J]. Front Pharmacol, 2024, 15: 1442831.
Huang D, Qiu M Q, Luo K H, et al. Puerarin prevents cadmium-induced endoplasmic reticulum stress via SIRT1-dependent PERK-CHOP pathway in HepG2 cells[J]. Acta Biochim Biophys Sin, 2025, 57(8): 1304-1311.
Yang C L, Wang X C. Lysosome biogenesis: Regulation and functions[J]. J Cell Biol, 2021, 220(6): e202102001.
Wang L Y, Fan R F, Yang D B, et al. Puerarin reverses cadmium-induced lysosomal dysfunction in primary rat proximal tubular cells via inhibiting Nrf2 pathway[J]. Biochem Pharmacol, 2019, 162: 132-141.
Jiang X J, Stockwell B R, Conrad M. Ferroptosis: Mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
Ding K Y, Liu C B, Li L, et al. Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism[J]. Chin Med J, 2023, 136(21): 2521-2537.
Huang Y, Yang J H, Lu T, et al. Puerarin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis through SLC7A11/GPX4/ACSL4 axis and alleviate pyroptosis through Caspase-1/GSDMD axis[J]. Mol Neurobiol, 2025, 62(7): 8931-8948.
Hou B Y, Ma P, Yang X Y, et al. In silico prediction and experimental validation to reveal the protective mechanism of puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy[J]. J Ethnopharmacol, 2024, 319(Pt2): 117281.
Jiang P Y, Zhou L Y, Zhao L Y, et al. Puerarin attenuates valproate-induced features of ASD in male mice via regulating SLC7A11-dependent ferroptosis[J]. Neuropsychopharmacology, 2024, 49(3): 497-507.
Fan X X, Liu S Q, Yu J, et al. Puerarin ameliorates the ferroptosis in diabetic liver injure through the JAK2/ STAT3 pathway inhibition based on network pharmacology and experimental validation[J]. Drug Des Devel Ther, 2025, 19: 737-757.
Jiang S, Qiu S H, Mu Y, et al. Puerarin reduces susceptibility to ventricular arrhythmias and inhibits ferroptosis via SIRT1/Nrf2 signaling in high-fat-diet rats[J]. Free Radic Biol Med, 2025, 227: 472-484.
Yang M M, Xia L Q, Song J, et al. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation[J]. Lipids Health Dis, 2023, 22(1): 202.
Song Q T, Zhao Y, Li Q, et al. Puerarin protects against iron overload-induced retinal injury through regulation of iron-handling proteins[J]. Biomed Pharmacother, 2020, 122: 109690.
Vasudevan S O, Behl B, Rathinam V A. Pyroptosis-induced inflammation and tissue damage[J]. Semin Immunol, 2023, 69: 101781.
Wei H Z, Sun M R, Wang R X, et al. Puerarin mitigated LPS-ATP or HG-primed endothelial cells damage and diabetes-associated cardiovascular disease via ROS-NLRP3 signalling[J]. J Cell Mol Med, 2024, 28(10): e18239.
Wang L, Xie X H, Chen Q Y, et al. Puerarin reduces diabetic nephropathy-induced podocyte pyroptosis by modulating the SIRT1/NLRP3/Caspase-1 pathway[J]. Mol Cell Endocrinol, 2025, 595: 112409.
Bock F J, Tait S W G. Mitochondria as multifaceted regulators of cell death[J]. Nat Rev Mol Cell Biol, 2020, 21(2): 85-100.
Zhang Y, Yang X, Ge X H, et al. Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved Caspase-3 and SIRT3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice[J]. Biomed Pharmacother, 2019, 109: 726-733.
Wu Y Y, Xue B, Li X J, et al. Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress[J]. Neural Regen Res, 2012, 7(33): 2583-2591.
Xu B Q, Li J D, Chen X L, et al. Puerarin attenuates cisplatin-induced apoptosis of hair cells through the mitochondrial apoptotic pathway[J]. Biochim Biophys Acta Mol Cell Res, 2022, 1869(4): 119208.
Xu Y X, Liang H, Mao X K, et al. Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K/Akt pathway: Network pharmacology and experimental verification[J]. J Cell Mol Med, 2024, 28(20): e70180.
马云飞. 葛根素注射液联合阿司匹林肠溶片、瑞舒伐他汀及美托洛尔治疗稳定型心绞痛患者的临床经验交流[J]. 哈尔滨医药, 2022, 42(4): 68-69.
张玉秀. 葛根素注射液治疗冠状动脉粥样硬化性心脏病不稳定型心绞痛临床效果分析[J]. 中医临床研究, 2020, 12(29): 42-45.
邵影. 葛根素注射液联合酒石酸美托洛尔治疗急性心力衰竭临床观察[J]. 实用中医药杂志, 2022, 38(7): 1207-1209.
何佩. 麝香保心丸联合葛根素注射液对急性非ST段抬高型心肌梗死患者心肌酶的影响[J]. 实用中西医结合临床, 2020, 20(15): 10-11.
范松. 高血压患者行葛根素与非洛地平联合治疗的临床效果研究[J]. 临床医药文献电子杂志, 2020, 7(54): 149-150.
罗侠, 包娟娟. 葛根素注射液对急性脑梗死患者侧支循环功能及预后的影响[J]. 吉林医学, 2025, 46(6): 1423-1426.
张明云. 葛根素注射液治疗急性脑梗塞的效果及对神经功能恢复的影响[J]. 临床医学研究与实践, 2022, 7(29): 62-64.
李显伟. 葛根素静脉滴注对脑出血后脑血管痉挛的治疗效果[J]. 中国药物经济学, 2023, 18(5): 93-96.
顾亮亮, 付国惠, 张保朝, 等. 葛根素注射液联合多奈哌齐治疗帕金森病的疗效观察[J]. 现代药物与临床, 2018, 33(5): 1230-1233.
杜敏晖, 李蓉煜, 庞凤. 葛根素对视神经萎缩患者神经功能、血液流变学的影响及临床疗效[J]. 辽宁中医杂志, 2025, 52(11): 101-104.
曾秀伟, 赵艳荣, 尚士博, 等. 葛根素注射液联合康柏西普治疗非增殖期糖尿病视网膜病变的临床研究[J]. 现代药物与临床, 2023, 38(2): 409-413.
王银歌, 王宝勇, 张德才. 葛根素葡萄糖注射液联合长春胺缓释胶囊治疗前部缺血性视神经病变的临床效果[J]. 药物评价研究, 2021, 44(1): 116-121.
潘学伟. 葛根素注射液联合甲泼尼龙琥珀酸钠对突发性耳聋患者ET、P-LPO水平的影响[J]. 医学理论与实践, 2022, 35(13): 2251-2253.
刘兴丽, 段艳红, 万勇军. 探讨葛根素注射液联合胰岛素治疗1型糖尿病患儿对血糖及氧化应激指标的影响[J]. 糖尿病新世界, 2025, 28(5): 121-124.
孟兰英. 葛根素治疗II型糖尿病患者胰岛素抵抗的临床分析[J]. 中医临床研究, 2020, 12(31): 100-102.
曹昌斧, 李富元. 葛根素注射液联合依帕司他治疗糖尿病周围神经病变的临床疗效[J]. 中国实用医药, 2023, 18(1): 32-35.
祁正宇, 褚梦倩. 葛根素辅助治疗肥胖型多囊卵巢综合征的效果[J]. 中国药物与临床, 2025, 25(5): 278-282.
李玲. 葛根素联合门冬胰岛素对妊娠期糖尿病孕妇生化指标及胎儿相关动脉血流参数的影响[J]. 世界中医药, 2018, 13(5): 1134-1138.
Kwok M K, Leung G M, Xu L, et al. Effect of puerarin supplementation on cardiovascular disease risk factors: A randomized, double-blind, placebo-controlled, 2-way crossover trial[J]. Biomed Pharmacother, 2022, 153: 113472.
He Y X, Liu M N, Wu H, et al. Puerarin: A hepatoprotective drug from bench to bedside[J]. Chin Med, 2024, 19(1): 139.
Li H W, Dong L, Liu Y, et al. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats[J]. Int J Pharm, 2014, 466(1/2): 133-138.
金昔陆, 程桂芳, 朱秀媛. 葛根素在健康志愿者的药代动力学[J]. 中国临床药理学杂志, 1991, 7(2): 115-118.
汪春燕, 陈绪龙, 汪新娌, 等. 葛根素脂质微球注射液、葛根素注射液药动学及对局灶性脑缺血再灌注大鼠的神经保护作用的比较研究[J]. 中药药理与临床, 2021, 37(3): 67-71.
Zhang L. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine[J]. Drug Deliv, 2019, 26(1): 860-869.
Anukunwithaya T, Poo P, Hunsakunachai N, et al. Absolute oral bioavailability and disposition kinetics of puerarin in female rats[J]. BMC Pharmacol Toxicol, 2018, 19(1): 25.
Cao L, Pu J, Cao Q R, et al. Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration[J]. Fitoterapia, 2013, 86: 202-207.
Zhang L L, Duan C C, Feng S Q, et al. Preparation and evaluation of puerarin-loaded PLGA nanoparticles for improving oral bioavailability in SD rats[J]. Biomed Pharmacother, 2024, 181: 117670.
Liu Y X, Zhao C G, Hu X, et al. ROS-responsive cinnamaldehyde polymer nanoparticles loaded with puerarin for the treatment of atherosclerosis[J]. ACS Omega, 2025, 10(23): 24396-24411.
Li T, Wang W Z, Liu W J, et al. Macrophage membrane coated functionalized nanoparticles for targeted drug delivery and neural function repair in cerebral ischemia-reperfusion injury[J]. Int J Pharm, 2025, 672: 125329.
Ling C L, Chen L L, Liang J M, et al. Neutrophil/ monocyte-targeted dual-ligands modified liposomes delivering puerarin for ischemia stroke treatment[J]. Mater Today Bio, 2025, 33: 102077.
Wang K, Sun Y, Zhu K, et al. Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery[J]. Biomaterials, 2025, 314: 122890.
Ma B, Miao Y X, Xu Y, et al. Evaluation of the antioxidant activity of the puerarin-β-lactoglobulin complex in vitro and in vivo[J]. NPJ Sci Food, 2025, 9(1): 169.
范仲雄, 于淑杰, 祝兴林, 等. 葛根素-磷脂复合物及其纳米药物递送系统的构建及其应用[J]. 厦门大学学报(自然科学版), 2026, 65(1): 92-106.
Liga S, Vodă R, Lupa L, et al. Synthesis of Ag₂O/Ag nanoparticles using puerarin: Characterization, cytotoxicity, in ovo safety profile, antioxidant, and antimicrobial potential against nosocomial pathogens[J]. J Funct Biomater, 2025, 16(7): 258.
Zhu W Q, Liu M L, Chi H W, et al. Preparation, structural characterization, and controlled release of puerarin-loaded complex and gel beads based on native/modified kudzu starch[J]. Food Chem, 2025, 493(Pt2): 145787.
Zhao Q X, Liu S L, Bi T, et al. Hydrogel-mediated mitochondrial reprogramming for inducing cell death: A novel approach to overcoming gemcitabine resistance in pancreatic ductal adenocarcinoma[J]. Mater Today Bio, 2025, 32: 101940.
Zhai S B, You J Q, Yang Z, et al. Near-infrared light-responsive on-demand puerarin-releasing injectable hydrogel for promoting healing of infected wounds[J]. Mater Today Bio, 2025, 32: 101817.
Yuan H, Zeng Z X, Li D R, et al. Multifunctional thiolated chitosan/puerarin composite hydrogels with pH/ glutathione dual responsiveness for potential drug carriers[J]. Int J Biol Macromol, 2024, 265(Pt2): 130841.
Zhang Y F, Liu K, Ma X J, et al. Therapeutic effects of puerarin loaded bone marrow mesenchymal stem cell-derived exosomes in a rat model of osteoarthritis[J]. Chem Biodivers, 2025, 22(3): e202402095.
张奇, 郝路格, 张鑫, 等. 载葛根素血浆外泌体的制备及其对体外血脑屏障模型通透性的影响[J]. 药学学报, 2025, 60(5): 1534-1542.
Long Y Q, Hu J, Liu Y, et al. Development of puerarin-loaded poly(lactic acid) microspheres for sustained ocular delivery: In vitro/vivo evaluation[J]. Eur J Pharm Biopharm, 2024, 204: 114524.
Su X C, Geng X R, Li F, et al. Microneedles loaded with L-arginine-modified puerarin-derived carbon nanoparticles improved treatment of diabetic wound via photothermal and nitric oxide-based gas therapy[J]. J Colloid Interface Sci, 2025, 691: 137353.

2026年第57卷第5期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.05.028

接收时间：2025-09-18
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-09-18

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.05.028

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT